Hong Kong Stock Exchange

Vaccine maker AIM Vaccine said on Monday it expects to report a net loss of 1.25 billion yuan to 1.38 billion yuan for last year, roughly quadruple its loss from 2022.

FAST NEWS: AIM Vaccine’s loss balloons

The latest: Vaccine maker AIM Vaccine Co. Ltd. (6660.HK) said on Monday it expects to report a net loss of 1.25 billion yuan ($174 million) to 1.38 billion yuan for last…
6660.HK
AIM Vaccine announced Friday that its shares were selected for inclusion in the MSCI Global Small Cap Index, effective after markets closed on Nov. 30.

FAST NEWS: AIM Vaccine named to MSCI small cap index

The latest: AIM Vaccine Co. Ltd. (6660.HK), China’s second-largest maker of non-Covid vaccines, announced Friday that its shares were selected for inclusion in the MSCI Global Small Cap Index, effective after…
6660.HK

Recent Articles

RELATED ARTICLES

  1. Clover Biopharmaceuticals posted a surge in first-half earnings after a $384 million grant for Covid vaccine development was belatedly folded into its accounts.
    With healthier finances, Clover Bio shifts to flu and RSV vaccines
    2197.HK
  2. Health Guard plans dual listing to fund HPV vaccine fight
  3. FAST NEWS: AIM Vaccine named to MSCI small cap index
    6660.HK
  4. Fosun Pharma, CanSino take different paths as Covid lift fade
    2196.HK 6185.HK
  5. China’s mRNA pioneer Stemirna faces post-Covid reinvention test
  6. FAST NEWS: CanSino receives Gates Foundation grant to develop polio vaccine
    6185.HK 688185.SHG
  7. FAST NEWS: CanSino’s revenue plunges as demand dries up for Covid vaccines
    6185.HK 688185.SHG
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo File-alt

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners